Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Tarsus Pharmaceuticals, Inc.
(TARS)
NASDAQ
:TARS
TARS
Tarsus Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Download TARS Report
Want to see TARS full AI Analyst Report?
Download
Tarsus Pharmaceuticals (TARS) Stock News & Sentiment
Download TARS Report
Follow
270
Followers
Premium
Company Announcements
Tarsus Advances TP-05 Lyme Prevention Trial, Setting Up a New Mid-Stage Catalyst for TARS Investors
9d ago
TARS
Premium
Company Announcements
Tarsus Pharmaceuticals Earnings Call Signals Durable Growth
23d ago
TARS
Premium
Market News
3 Best Growth Stocks to Buy in May 2026, According to Analysts
25d ago
NFLX
PANW
Premium
Ratings
Buy Rating Reaffirmed on XDEMVY as Inventory Dynamics Seen as Transient and $88 Price Target Remains Unchanged
25d ago
TARS
Premium
Ratings
Buy Rating Backed by Blockbuster Xdemvy Launch and TP-05 Lyme Prevention Opportunity
2M ago
TARS
Premium
Company Announcements
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth
3M ago
TARS
Premium
Ratings
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline
3M ago
TARS
More TARS News >
TARS News on the Web
All News
Bearish News
Bullish News
2026-05-27
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
2026-05-26
Tarsus Pharmaceuticals (TARS) Gets a Buy from H.C. Wainwright
TipRanks News
Bullish
2026-05-24
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter | The Motley Fool
Motley Fool
Neutral
2026-05-20
Tarsus Advances TP-05 Lyme Prevention Trial, Setting Up a New Mid-Stage Catalyst for TARS Investors
TipRanks News
Bullish
2026-05-15
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Tarsus Pharmaceuticals (TARS) and Jasper Therapeutics (JSPR)
TipRanks News
Bullish
2026-05-14
PRUDENTIAL FINANCIAL INC Acquires Significant Stake in Tarsus Pharmaceuticals Inc
GuruFocus News
Bullish
2026-05-13
Why Tarsus Pharmaceuticals Stock Is Surging Today
TipRanks News
Bullish
2026-05-08
Tarsus Pharmaceuticals Stock Takes a Sudden Nosedive
TipRanks News
Bearish
145
Results | Showing
1
out of
19
News Score - Last 7 Days
Very Positive
TARS
Sector Average
Media Buzz
This Week
3 articles
Weekly Average
4.5 articles
News Sentiment
This Week
99%
Sector Average
79%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is TARS’s Media Buzz Sentiment?
3 articles about TARS were published this week. In an average week, 4.5 articles are published.
What is TARS’s weekly average amount of articles?
In an average week, 4.5 articles about TARS are published.
What is TARS’s News Sentiment?
99% of articles about TARS were positive this week, compared to its sector average of 79%.
Healthcare Stocks that are Trending in the News
AKTX
Akari Therapeutics
IMMX
Immix Biopharma
SY
So-Young International
ADO
AnteoTech Ltd
FSPKF
Fisher & Paykel Healthcare Corporation Limited
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.